Prevalence of exclusion criteria
| . | Patients with bleeding, cases . | Patients without bleeding, controls . |
|---|---|---|
| Atrial fibrillation, n (%) | 638 | 648 |
| Not suitable for anticoagulation | 194 (30) | 94 (15) |
| Cardiac comorbidity | 40 (6) | 43 (7) |
| Previous stroke | 17 (3) | 25 (4) |
| Comedication* | 171 (27) | 87 (13) |
| Venous thromboembolism, n (%) | 141 | 147 |
| Not suitable for anticoagulation | 22 (16) | 14 (10) |
| Comorbidity/cancer | 20 (14) | 7 (5) |
| Risk factors for thrombosis | 2 (1) | 3 (2) |
| Comedication* | 9 (6) | 5 (3) |
| Acute coronary syndromes, n (%) | 214 | 198 |
| Not suitable for anticoagulation | 30 (14) | 25 (13) |
| Cardiac comorbidity | 34 (16) | 23 (12) |
| Comedication* | 70 (33) | 28 (14) |
| . | Patients with bleeding, cases . | Patients without bleeding, controls . |
|---|---|---|
| Atrial fibrillation, n (%) | 638 | 648 |
| Not suitable for anticoagulation | 194 (30) | 94 (15) |
| Cardiac comorbidity | 40 (6) | 43 (7) |
| Previous stroke | 17 (3) | 25 (4) |
| Comedication* | 171 (27) | 87 (13) |
| Venous thromboembolism, n (%) | 141 | 147 |
| Not suitable for anticoagulation | 22 (16) | 14 (10) |
| Comorbidity/cancer | 20 (14) | 7 (5) |
| Risk factors for thrombosis | 2 (1) | 3 (2) |
| Comedication* | 9 (6) | 5 (3) |
| Acute coronary syndromes, n (%) | 214 | 198 |
| Not suitable for anticoagulation | 30 (14) | 25 (13) |
| Cardiac comorbidity | 34 (16) | 23 (12) |
| Comedication* | 70 (33) | 28 (14) |
Comedication: other antithrombotic agents, in particular antiplatelet agents, including aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), and clopidogrel.